Research Tool
Compare Peptides
Select two peptides to view a side-by-side breakdown of their profiles, mechanisms, and research data.
Research Status
Preclinical
Phase II
Half-Life
~2 hours
~1–2 hours
Mol. Weight
711.86 Da
817.99 Da
Admin Routes
subcutaneous
subcutaneous, intranasal
Categories
Growth Hormone Axis
Growth Hormone Axis, Sleep & Circadian
Interaction
additive
Both ipamorelin and GHRP-2 are GHS-R1a agonists but differ in selectivity and side-effect profile; combining them appears to produce additive GH release with overlapping rather than synergistic receptor engagement.
emerging
Mechanism
Pharmacokinetics
Research Findings
Safety